Small fiber neuropathy DOI
Dennis Kool, Janneke G. J. Hoeijmakers,

Stephen G. Waxman

и другие.

International review of neurobiology, Год журнала: 2024, Номер unknown, С. 181 - 231

Опубликована: Янв. 1, 2024

Язык: Английский

Pathology of pain and its implications for therapeutic interventions DOI Creative Commons
Bo Cao,

Qixuan Xu,

Yajiao Shi

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Июнь 8, 2024

Abstract Pain is estimated to affect more than 20% of the global population, imposing incalculable health and economic burdens. Effective pain management crucial for individuals suffering from pain. However, current methods assessment treatment fall short clinical needs. Benefiting advances in neuroscience biotechnology, neuronal circuits molecular mechanisms critically involved modulation have been elucidated. These research achievements incited progress identifying new diagnostic therapeutic targets. In this review, we first introduce fundamental knowledge about pain, setting stage subsequent contents. The review next delves into underlying disorders, including gene mutation, epigenetic modification, posttranslational inflammasome, signaling pathways microbiota. To better present a comprehensive view research, two prominent issues, sexual dimorphism comorbidities, are discussed detail based on findings. status quo evaluation manipulation summarized. A series improved innovative strategies, such as therapy, monoclonal antibody, brain-computer interface microbial intervention, making strides towards application. We highlight existing limitations future directions enhancing quality preclinical research. Efforts decipher complexities pathology will be instrumental translating scientific discoveries practice, thereby improving bench bedside.

Язык: Английский

Процитировано

31

Neuropathic pain; what we know and what we should do about it DOI Creative Commons
Peter A. Smith

Frontiers in Pain Research, Год журнала: 2023, Номер 4

Опубликована: Сен. 22, 2023

Neuropathic pain can result from injury to, or disease of the nervous system. It is notoriously difficult to treat. Peripheral nerve promotes Schwann cell activation and invasion immunocompetent cells into site injury, spinal cord higher sensory structures such as thalamus cingulate cortices. Various cytokines, chemokines, growth factors, monoamines neuropeptides effect two-way signalling between neurons, glia immune cells. This sustained hyperexcitability spontaneous activity in primary afferents that crucial for onset persistence well misprocessing information supraspinal structures. Much current understanding aetiology identification drug targets derives studies consequences peripheral rodent models. Although a vast amount has been forthcoming, translation this clinical arena minimal. Few, if any, major therapeutic approaches have appeared since mid 1990's. may reflect failure recognise differences processing males vs. females, cellular responses different types humans animals. Basic science which seek bridge knowledge gap include better assessment animal models, use models emulate human disease, stratification phenotypes according quantitative signs symptoms disease. lead more personalized effective treatments individual patients. Significance statement: There an urgent need find new neuropathic pain. classical revealed essential features central sensitization some molecular mechanisms involved, they do not adequately model multiplicity states injuries bring forth clinic. review seeks integrate disciplines understand pain; including immunology, biology, electrophysiology biophysics, anatomy, neurology, pharmacology behavioral science. Beyond this, it underlines ongoing refinements basic practice will engender improved management.

Язык: Английский

Процитировано

24

Skin Biopsy DOI
Dennis Kool,

Mirna Andelic,

Raffaella Lombardi

и другие.

Elsevier eBooks, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Процитировано

0

Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic pain DOI
Ran Guo, Chen Ouyang, Yang Zhou

и другие.

Cell, Год журнала: 2025, Номер unknown

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0

miRNA packaging into small extracellular vesicles and implications in pain DOI Creative Commons

Jason Tyler DaCunza,

Jason Wickman, Seena K. Ajit

и другие.

PAIN Reports, Год журнала: 2024, Номер 9(6), С. e1198 - e1198

Опубликована: Окт. 23, 2024

Abstract Extracellular vesicles (EVs) are a heterogenous group of lipid bilayer bound particles naturally released by cells. These classified based on their biogenesis pathway and diameter. The overlap in size exosomes generated from the exosomal macrovesicles that pinched off surface plasma membrane makes it challenging to isolate pure populations. Hence, isolated less than 200 nm called small extracellular (sEVs). transport variety cargo molecules, multiple mechanisms govern packaging into sEVs. Here, we discuss current understanding how miRNAs targeted sEVs, including role RNA binding proteins EXOmotif sequences present sEV loading. Several studies human pain disorders rodent models have reported alterations cargo, miRNAs. sorting target regulation miR-939, miRNA altered individuals with complex regional syndrome, is discussed context inflammation. We also provide broad overview therapeutic strategies being pursued utilize sEVs clinic work needed further our EVs successfully deploy as therapeutic.

Язык: Английский

Процитировано

1

Small fiber neuropathy DOI
Dennis Kool, Janneke G. J. Hoeijmakers,

Stephen G. Waxman

и другие.

International review of neurobiology, Год журнала: 2024, Номер unknown, С. 181 - 231

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

1